Day One Announces Ojemdaâ„¢ 2025 Revenue & 2026 Guidance
Day One Biopharmaceuticals reported preliminary 2025 net product revenue of $155.4 million for Ojemda, up 172% year over year,...
Day One Biopharmaceuticals reported preliminary 2025 net product revenue of $155.4 million for Ojemda, up 172% year over year,...
Nicox has repaid all secured debt owed to Kreos Capital and secured up to €4 million in new unsecured...
CorMedix Therapeutics has consolidated its leadership bench as it scales into a multi-brand anti-infectives and hospital products company. The...
Collegium Pharmaceutical set 2026 guidance at $805–$825 million in net product revenue with adjusted EBITDA of $455–$475 million, anchored...
Alvotech disclosed two insider transactions filed with the Luxembourg financial regulator: ATP Holdings ehf., identified as a manager or...
ATP Holdings ehf has acquired 6,922,897 shares in Alvotech across two market transactions on December 17 and December 19,...
ATP Holdings ehf. has filed two manager-and-related-party transactions with Luxembourg’s market regulator involving Alvotech: an acquisition of 4,812,257 shares...
Enlivex Therapeutics’ primary digital treasury asset, the Rain token, began trading on KuCoin on January 6, 2026, expanding secondary...
Relation and Deerfield Management have formed a research collaboration that allows Relation to nominate AI- and biology-derived targets for...
Nicox has repaid all secured debt with Kreos Capital and secured up to €4 million in new unsecured bond...